Health Care

The drugstore chain posted its third consecutive quarterly profit helped by sales of higher-margin generic drugs. 

Johnson & Johnson agreed to acquire privately held drug developer Aragon Pharmaceuticals for as much as $1 billion.

After the Obama administration decided to allow the contraceptive to be sold over the counter without restrictions, drug makers are facing questions over how to market the pill to teens—or whether they should at all.

The highest U.S. court ruled Thursday biotech companies can’t patent your genes. But they can stake claim to derivatives made from the building blocks of nearly all living things.

Pfizer has reached a $2.15 billion settlement with the two companies over patent infringement on its acid-reflux drug Protonix.

Ista Pharmaceuticals pleaded guilty to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain.

The Department of Health and Human Services announced a $1 billion initiative to fund innovations in federal healthcare programs.

Merck posted weaker-than-expected quarterly sales on increased generic competition as well as a sharp revenue miss and lowered its full-year outlook.

The pharmacy retailer reported lower input costs while margins widened amid an influx of new generic drugs.

U.S. federal prosecutors filed a lawsuit against Novartis Pharmaceuticals, accusing the company of paying kickbacks to doctors in an effort to encourage prescriptions for Novartis drugs.

Bristol-Myers Squibb reported lower first-quarter earnings, in line with forecasts, thanks to unexpectedly lower taxes and sharply higher sales.

The company reported higher-than-expected quarterly earnings due to favorable taxes and cost controls, but sales missed expectations.

The blue-chip insurer posted quarterly profits that topped expectations, but sales missed estimates and the company sharply lowered its outlook. 

The world's largest household products company is reportedly seeking to pay its bills in 75 days from the average of 45 days it takes currently.

The health care company earnings from continuing operations were roughly in line with forecasts, rising on demand for its nutritional and diagnostic products.

The medical technology company reported first-quarter net earnings were $222 million compared with $212 million the year prior.

China's Ministry of Commerce conditionally backed the $35 billion deal, the largest merger in mining history.

The pharmaceutical company plans reduce its U.S. sales group by nearly 1,000 representatives as part of a major restructuring, according to a report Thursday by Dow Jones Newswires.

The nominee to lead the healthcare agency said it was investigating events surrounding a decision on Medicare Advantage payment rates that sent shares of insurance companies soaring.

Rite Aid unexpectedly swung to a profit in the 2Q, as it continued to log higher sales while generic drugs boosted margins.